Remimazolam for confusion after pediatric brain surgery
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests a medicine called remimazolam to see if it reduces confusion and agitation (emergence delirium) when children wake up from brain surgery. It may help your child have a smoother recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 1 and 6 years old.
- Your child is scheduled for planned brain surgery (neurosurgery) that will need general anesthesia.
- The surgery is expected to last more than 1 hour.
- Your child is not allergic to benzodiazepines (a class of calming medicines).
- Your child has not taken other sedatives within 12 hours before the surgery.
- Your child can complete the assessment for emergence delirium (e.g., no severe language, hearing, or vision problems).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies brain activity (EEG) in children receiving remimazolam, a type of anesthesia. It aims to understand how the drug affects the brain during surgery.
This trial tests a medication called Remimazolam Besylate to sedate patients who need a breathing tube after heart surgery. The goal is to help patients relax while they recover in the intensive care unit.
This study uses brain scans to see how a new sedative called remimazolam affects the brain in healthy adults. It will help researchers understand the drug's effects and ensure it's safe.
This study tests whether a sedation drug called remimazolam can help protect your kidneys during liver or pancreas surgery. If you are having one of these surgeries, you might be able to join.
This study tests a computerized dosing system for a sedation medicine called remimazolam during general anesthesia. It is for adults having planned surgery and aims to see if the computer-guided dosing is safe and effective.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Hear when a new Neurosurgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.